This topic contains a solution. Click here to go to the answer

Author Question: At the workplace, women and racial and ethnic minorities face ________ that keep them from moving ... (Read 43 times)

khang

  • Hero Member
  • *****
  • Posts: 569
At the workplace, women and racial and ethnic minorities face ________ that keep them from moving laterallyto jobs that might lead to broader experience.
 
  a. glass cliffs
  b. glass escalators
  c. glass ceilings
  d. glass walls

Question 2

Portraying the problems of racial and ethnic minorities as their fault rather than recognizing society's responsibilities is an instance of ________.
 
  a. victim discounting
  b. blaming the victim
  c. the scapegoating theory
  d. the melting pot



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meryzewe

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

d

Answer to Question 2

b




khang

  • Member
  • Posts: 569
Reply 2 on: Aug 8, 2018
YES! Correct, THANKS for helping me on my review


ricroger

  • Member
  • Posts: 352
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library